Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Lung Cancer. 2012 Jan 21;76(3):410–415. doi: 10.1016/j.lungcan.2011.12.006

Table 1.

Demographics of chemotherapy only patients on E1594 and E4599 (N = 1590) divided into age/sex cohorts using age 60 as a cut-point.

Total Age <60 years Age ≥60 years
1590 (100%) 664 (41.8%) 926 (58.2%)
Female 611(38.4%) 274(41.3%) 337(36.4%)
Male 879 (61.6%) 390 (58.7%) 589 (63.6%)
PS 0 522 (32.8%) 232 (35%) 290 (31.4%)
PS1 1000 (62.9%) 408 (61.6%) 592 (64%)
PS2 65 (4.1%) 22 (3.3%) 43 (4.6%)
Stage IIIB 205 (12.9%) 87 (13.1%) 118 (12.8%)
Stage IV 1382 (86.9%) 576 (86.9%) 806 (87.2%)
Wt loss >10% 182(11.4%) 79(11.9%) 103(11.1%)

PS, performance status on the Eastern Cooperative Oncology Group scale; wt, weight.